Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Experimental and Molecular Modeling Techniques to Investigate the Buffer Effects on Glucagon Stability.

Pharmaceutical research·2026
Same author

Impact of Silicone Oil and Storage Conditions on the Physicochemical and Functional Stability of mRNA-LNPs: The Critical Role of mRNA Structure.

Molecular pharmaceutics·2026
Same author

The Stealth Hazard: Tungsten in Prefilled Syringes Induces mRNA Degradation and Functional Loss in Lipid Nanoparticles Despite Apparent Biophysical Stability.

Molecular pharmaceutics·2026
Same author

The Detrimental Effects of Crystalline Excipients: How They Jeopardize the Long-Term Stability of Freeze-Dried Polypeptide Formulations.

Pharmaceutics·2025
Same author

Contradictory Effects of Different Freezing Rates on Visible Bubbles and Reconstitution Time during the Reconstitution of Freeze-Dried High-Concentration Monoclonal Antibody Formulations.

Molecular pharmaceutics·2025
Same author

Compatibility between Proteins and Polysaccharide Excipients in Oral Delivery Tablets.

Molecular pharmaceutics·2025
Same journal

Leveraging Carnitine-functionalized Lipid Nanocarrier based Targeted Delivery of A1874 PROTAC for Glioblastoma.

Pharmaceutical research·2026
Same journal

Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

Pharmaceutical research·2026
Same journal

Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis.

Pharmaceutical research·2026
Same journal

Spray Dried Lysozyme Microspheres: Morphological Evolution and Enzymatic Activity Retention.

Pharmaceutical research·2026
Same journal

Colloidal Stability of Amorphous Nanoparticles in Solution: Impact of Stabilizer.

Pharmaceutical research·2026
Same journal

Impact of Mixing Approach and Bubble Formation on In Situ Forming Implant Properties.

Pharmaceutical research·2026
See all related articles

Related Experiment Video

Updated: May 31, 2025

Methods to Identify the NMR Resonances of the 13C-Dimethyl N-terminal Amine on Reductively Methylated Proteins
13:59

Methods to Identify the NMR Resonances of the 13C-Dimethyl N-terminal Amine on Reductively Methylated Proteins

Published on: December 12, 2013

6.2K

A Novel Peptide Mapping Method Utilizing Cysteine as a Reducing Agent.

Jun-Ting Fang1,2, Si-Tao Wang1, Haibin Wang3

  • 1Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.

Pharmaceutical Research
|January 23, 2025
PubMed
Summary
This summary is machine-generated.

Cysteine (Cys) offers a safe and effective alternative to traditional reducing agents like DTT for peptide mapping. This novel method using Cys provides high protein sequence coverage and broad applicability for monoclonal antibodies and proteins.

Keywords:
cysteinedithiothreitolmonoclonal antibodypeptide mappingreducing agent

More Related Videos

Sample Preparation and Relative Quantitation using Reductive Methylation of Amines for Peptidomics Studies
08:00

Sample Preparation and Relative Quantitation using Reductive Methylation of Amines for Peptidomics Studies

Published on: November 4, 2021

2.3K
Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry
12:07

Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry

Published on: March 24, 2012

16.2K

Related Experiment Videos

Last Updated: May 31, 2025

Methods to Identify the NMR Resonances of the 13C-Dimethyl N-terminal Amine on Reductively Methylated Proteins
13:59

Methods to Identify the NMR Resonances of the 13C-Dimethyl N-terminal Amine on Reductively Methylated Proteins

Published on: December 12, 2013

6.2K
Sample Preparation and Relative Quantitation using Reductive Methylation of Amines for Peptidomics Studies
08:00

Sample Preparation and Relative Quantitation using Reductive Methylation of Amines for Peptidomics Studies

Published on: November 4, 2021

2.3K
Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry
12:07

Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry

Published on: March 24, 2012

16.2K

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Protein Chemistry

Background:

  • Conventional reducing agents like β-mercaptoethanol (β-ME) and dithiothreitol (DTT) present odor and toxicity challenges in protein analysis.
  • There is a need for safer, more accessible reducing agents in peptide mapping workflows.

Purpose of the Study:

  • To introduce and evaluate cysteine (Cys) as a novel, non-toxic, and odorless reducing agent for peptide mapping.
  • To compare the efficacy of Cys with established reducing agents like DTT for monoclonal antibody (mAb) analysis.

Main Methods:

  • Exploration of Cys reducing efficacy across various concentrations (10-40 mM) and pH levels (7.0-11.0).
  • Comparative analysis using reversed-phase high-performance liquid chromatography (RP-HPLC) and UV chromatograms.
  • Primary sequence characterization of a specific mAb (mAb-1) using liquid chromatography-mass spectrometry (LC-MS).

Main Results:

  • Cys demonstrated comparable UV chromatograms and overall similarity to DTT across tested conditions.
  • Optimal reducing efficacy was observed between 10-40 mM Cys and pH 7.0-11.0.
  • Achieved 97% overall sequence coverage for mAb-1, with consistent results for other proteins and mAbs.

Conclusions:

  • Cysteine (Cys) is a viable, non-toxic, and odorless alternative to DTT for disulfide bond reduction in peptide mapping.
  • This Cys-based method shows broad applicability for analyzing various proteins and monoclonal antibodies.
  • The study highlights Cys as a promising reagent for advancing protein characterization techniques.